|
UBL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44249065417534E-15 |
| Normal-vs-Stage2 |
3.97815114183686E-12 |
| Normal-vs-Stage3 |
2.28894680986969E-12 |
| Normal-vs-Stage4 |
1.030120E-02 |
| Stage1-vs-Stage2 |
9.352200E-01 |
| Stage1-vs-Stage3 |
3.894600E-01 |
| Stage1-vs-Stage4 |
6.321400E-01 |
| Stage2-vs-Stage3 |
4.641400E-01 |
| Stage2-vs-Stage4 |
5.912600E-01 |
| Stage3-vs-Stage4 |
2.781200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.18410001195934E-09 |
| Normal-vs-Asian |
1.884050E-02 |
| Caucasian-vs-AfricanAmerican |
1.833040E-01 |
| Caucasian-vs-Asian |
9.842400E-01 |
| AfricanAmerican-vs-Asian |
6.185800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
7.06434910568987E-13 |
| Male-vs-Female |
1.603580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.581700E-04 |
| Normal-vs-Extreme_Weight |
1.63258295771129E-12 |
| Normal-vs-Obese |
1.63591362678517E-12 |
| Normal-vs-Extreme_Obese |
1.558400E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.817400E-01 |
| Normal_Weight-vs-Obese |
5.805000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.544200E-01 |
| Extreme_Weight-vs-Obese |
3.005400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.615800E-01 |
| Obese-vs-Extreme_Obese |
7.047000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.54759990880871E-10 |
| Normal-vs-Age(41-60Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(61-80Yrs) |
1.83186799063151E-14 |
| Normal-vs-Age(81-100Yrs) |
2.00859995302949E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.258400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.223800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.472400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.778800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.763400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.704000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.49020035095293E-10 |
| Normal-VS-KIRP CIMP |
5.74700000033346E-07 |
| Normal-VS-Unclassified PRCC |
4.2993000048952E-08 |
| Type1 PRCC-VS-Type2 PRCC |
6.725000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.729600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.194300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.439200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.804000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.143200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.07489999995525E-06 |
| Normal-vs-N2 |
4.90659999996534E-06 |
| N0-vs-N1 |
1.420820E-01 |
| N0-vs-N2 |
6.935800E-01 |
| N1-vs-N2 |
4.118000E-01 |
|
|
